Los Angeles Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184K | Buy |
+74,917
| New | +$184K | ﹤0.01% | 1208 |
|
|
2024
Q3 | – | Sell |
-24,518
| Closed | -$528K | – | 1271 |
|
|
2024
Q2 | $528K | Hold |
24,518
| – | – | ﹤0.01% | 838 |
|
|
2024
Q1 | $661K | Hold |
24,518
| – | – | ﹤0.01% | 800 |
|
|
2023
Q4 | $735K | Buy |
24,518
+10,538
| +75% | +$316K | ﹤0.01% | 774 |
|
|
2023
Q3 | $286K | Buy |
+13,980
| New | +$286K | ﹤0.01% | 968 |
|
|
2021
Q4 | – | Sell |
-8,190
| Closed | -$245K | – | 1470 |
|
|
2021
Q3 | $245K | Hold |
8,190
| – | – | ﹤0.01% | 1371 |
|
|
2021
Q2 | $363K | Sell |
8,190
-500
| -6% | -$22.2K | ﹤0.01% | 1313 |
|
|
2021
Q1 | $386K | Sell |
8,690
-1,665
| -16% | -$74K | ﹤0.01% | 1334 |
|
|
2020
Q4 | $568K | Buy |
+10,355
| New | +$568K | ﹤0.01% | 1158 |
|